OHSU is ranked as the top hospital in Oregon for 2023-24.

OHSU is ranked as the top hospital in Oregon for 2023-24.

George Thomas, M.D., is named an advisory board member to Auron Therapeutics, platform-based, product-driven biotechnology company focused on developing novel cancer therapies that target cellular plasticity.

A nationwide clinical trial led by Christopher W. Ryan, M.D., tests drug everolimus in treating kidney cancer.

New research reveals a promising treatment in stopping the progression of amyotrophic lateral sclerosis. Senior author Bahareh Ajami, Ph.D., says, “At this point, we cannot say it’s a cure but it’s a very interesting start. It may be similar to what immunotherapy did for cancer or will do for Alzheimer’s by targeting immune cells."

New research reveals a promising treatment in stopping the progression of amyotrophic lateral sclerosis. Senior author Bahareh Ajami, Ph.D., says, “At this point, we cannot say it’s a cure but it’s a very interesting start. It may be similar to what immunotherapy did for cancer or will do for Alzheimer’s by targeting immune cells."

The police bureau has been conducting targeted stings over the past two years, but recently refined its methods with help from Oregon Health & Science University researchers.

Former OHSU neuroscientist authors perspective in Vox critiquing animal research.

Oregon Gov. Tina Kotek has given notice that she may veto a section of a bill that would have provided $500,000 for an OHSU study on the effects of current laws and policies on people in the sex trade.

In a KFF Health News story published by CBS News, The Oregonian and other outlets across the country, Brett Dodson says OHSU’s program to provide RV parking spaces for patients and families is an option for many families driving from eight to 10 hours away. He says, “They’ve seen the rural clinics and they need to come to that next level. When they do, I think they’re more comfortable with an RV than they are trying to find a hotel.”